<?xml version='1.0' encoding='utf-8'?>
<document id="28674061"><sentence text="Assessment of Clinical Pharmacokinetic Drug-Drug Interaction of Antimalarial Drugs α/β-Arteether and Sulfadoxine-Pyrimethamine." /><sentence text="Antimalarial drug combination therapy is now being widely used for the treatment of uncomplicated malaria" /><sentence text=" The objective of the present study was to investigate the effects of coadministration of intramuscular α/β-arteether (α/β-AE) and oral sulfadoxine-pyrimethamine (SP) on the pharmacokinetic properties of each drug as a drug-drug interaction study to support the development of a fixed-dose combination therapy"><entity charOffset="136-147" id="DDI-PubMed.28674061.s3.e0" text="sulfadoxine" /><entity charOffset="148-161" id="DDI-PubMed.28674061.s3.e1" text="pyrimethamine" /><entity charOffset="163-165" id="DDI-PubMed.28674061.s3.e2" text="SP" /><pair ddi="false" e1="DDI-PubMed.28674061.s3.e0" e2="DDI-PubMed.28674061.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28674061.s3.e0" e2="DDI-PubMed.28674061.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28674061.s3.e0" e2="DDI-PubMed.28674061.s3.e2" /><pair ddi="false" e1="DDI-PubMed.28674061.s3.e1" e2="DDI-PubMed.28674061.s3.e1" /><pair ddi="false" e1="DDI-PubMed.28674061.s3.e1" e2="DDI-PubMed.28674061.s3.e2" /></sentence><sentence text=" A single-dose, open-label, crossover clinical trial was conducted in healthy adult Indian male volunteers (18 to 45 years, n = 13) who received a single dose of AE or SP or a combination dose of AE and SP"><entity charOffset="168-169" id="DDI-PubMed.28674061.s4.e0" text="SP" /><entity charOffset="203-204" id="DDI-PubMed.28674061.s4.e1" text="SP" /><pair ddi="false" e1="DDI-PubMed.28674061.s4.e0" e2="DDI-PubMed.28674061.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28674061.s4.e0" e2="DDI-PubMed.28674061.s4.e1" /></sentence><sentence text=" Blood samples were collected up to 21 days postadministration, and concentrations of α-AE, β-AE, sulfadoxine, and pyrimethamine were determined by using a validated liquid chromatography-tandem mass spectrometry method"><entity charOffset="98-109" id="DDI-PubMed.28674061.s5.e0" text="sulfadoxine" /><entity charOffset="115-128" id="DDI-PubMed.28674061.s5.e1" text="pyrimethamine" /><pair ddi="false" e1="DDI-PubMed.28674061.s5.e0" e2="DDI-PubMed.28674061.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28674061.s5.e0" e2="DDI-PubMed.28674061.s5.e1" /></sentence><sentence text=" Pharmacokinetic parameters were calculated and statistically analyzed to calculate the geometric mean ratio and confidence interval" /><sentence text=" Following single-dose coadministration of intramuscular AE and oral SP, the pharmacokinetic properties of α/β-AE were not significantly affected, and α/β-AE had no significant effect on the pharmacokinetic properties of SP in these selected groups of healthy volunteers"><entity charOffset="69-81" id="DDI-PubMed.28674061.s7.e0" text="SP" /><entity charOffset="221-233" id="DDI-PubMed.28674061.s7.e1" text="SP" /><pair ddi="false" e1="DDI-PubMed.28674061.s7.e0" e2="DDI-PubMed.28674061.s7.e0" /><pair ddi="false" e1="DDI-PubMed.28674061.s7.e0" e2="DDI-PubMed.28674061.s7.e1" /></sentence><sentence text=" However, more investigations are needed to explore this further" /><sentence text=" (This study has been registered in the clinical trial registry of India under approval no" /><sentence text=" CTRI/2011/11/002155" /><sentence text=")" /><sentence text="" /></document>